Photo credit: MSF Press release Press release | 25 July 2024 Diagnostics MSF and partners protest medical test maker Cepheid and Danaher at International AIDS Conference 3 min
Photo credit: MSF Press release Press release | 23 July 2024 HIV/AIDS Activists at AIDS2024 Demand: Break Gilead’s Lenacapavir Monopoly Gilead’s Price 100,000% Higher than Target Generic Price for 100% Effective Prevention Shot 3 min
Press release Press release | 17 July 2024 Tuberculosis MSF welcomes Indian Patent Office’s rejection of J&J’s application for paediatric formulation of lifesaving TB drug 4 min
Press release | 05 July 2024 Intellectual property and trade Tuberculosis South Africa MSF and Health Justice Initiative welcome J&J’s withdrawal of patents on lifesaving TB drug in South Africa
Photo credit: Jose Cendon The GeneXpert machine can identify the bacteria responsabile for tuberculosis (Mycobacterium tuberculosis) and also drug resistant TB Press release Press release | 17 June 2024 Diagnostics Danaher continues to charge exorbitant prices for lifesaving medical tests despite urgent demands for price reductions by several Ministries of Health 4 min
Copyright: Bruno De Cock Press release Press release | 06 June 2024 Tuberculosis Europe Urgent call for Europe to improve treatment access for tuberculosis 5 min
Photo credit: MSF/Chris Allan Press release Press release | 04 June 2024 Pandemic preparedness MSF responds to the outcomes of PPR negotiations at WHA77 2 min
Photo credit: Johnny Vianney Bissakonou/MSF Press release Press release | 04 June 2024 Vaccines NEWS UPDATE: Gavi’s next strategy must make sure to reach the 10 million children in fragile and humanitarian settings who are missing vaccines 3 min
